Thu, May 12, 2022

Tejas Savant Maintained (BDSX) at Hold with Decreased Target to $5 on, May 12th, 2022

Tejas Savant of Morgan Stanley, Maintained "Biodesix, Inc." (BDSX) at Hold with Decreased Target from $7 to $5 on, May 12th, 2022.

Tejas has made no other calls on BDSX in the last 4 months.



There is 1 other peer that has a rating on BDSX. Out of the 1 peers that are also analyzing BDSX, 0 agree with Tejas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Tejas


  • Max Masucci of "Cowen & Co." Initiated at Buy on, Wednesday, April 20th, 2022